1-8 of 8
netupitant
Close
Sort by
Journal Articles

Phase II Multicenter, Not Comparative, Study of Multiple Doses of NEPA (netupitant + palonosetron) in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in Non-Hodgkin Lymphoma Patients Eligible for Autologous Hematopoietic Stem Cell Transplantation Receiving Multiple Days / High Dose Chemotherapy Regimens

Nicola Di Renzo, MD, Maurizio Musso, MD, Rosanna Scimè, MD, Giuseppe Milone, MD PhD, Tommasina Perrone, MD, Clara De Risi, MD, Domenico Pastore, MD PhD, Attilio Guarini, MD, Andrea Mengarelli, MD, Fabio Benedetti, MD, Patrizio Mazza, MD, Vera Capria, MD, Patrizia Chiusolo, Luca Cupelli, MD, Vincenzo Federico, MD, Valentina Bozzoli, PhD MD, Anna Rita Messa, Giorgina Specchia, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1974.
https://doi.org/10.1182/blood-2019-125071
Published: 2019
Journal Articles

NEPA (netupitant + palonosetron) Administration Is Safe and Effective in cHL Patients Receiving ABVD Regimen: A Single-Center Real Life Experience

Vittorio Ruggero Zilioli, Periana Minga, Lara Crucitti, Erika Meli, Monica Luigia Torretta, Anna Esposito, Chiara Rusconi, Roberto Cairoli
Journal: Blood
Blood (2018) 132 (Supplement 1): 5374.
https://doi.org/10.1182/blood-2018-99-116543
Published: 2018
Journal Articles

Targeting Central Mechanisms of Pain to Improve Acupuncture Analgesia in a Humanized Mouse Model of Sickle Cell Disease

Ying Wang, MD PhD, Jianxun Lei, PhD, Kalpna Gupta, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1064.
https://doi.org/10.1182/blood-2018-99-115577
Published: 2018
Journal Articles

Patient Reported Outcome (PRO) in Patients Receiving High and Moderate Emetogenic Chemotherapy (Ctx) - Results of a German Prospective Non-Interventional Study with Netupitant/Palonosetron Fixed Dose Combination (NEPA)

Meinolf Karthaus, P Klare, N Gazawi, MO Zahn, B Reimann, S Busch, Joerg Schilling
Journal: Blood
Blood (2018) 132 (Supplement 1): 4844.
https://doi.org/10.1182/blood-2018-99-113489
Published: 2018
Journal Articles

Quality of Life and Patient Reported Outcome (PRO) in Patients Receiving High and Moderate Emetogenic Chemotherapy (Ctx) - Results of a German Non-Interventional Study with NEPA - a Netupitant/Palonosetron Fixed Dose Combination

Meinolf Karthaus, MD, P Klare, V Heilmann, G Klausmann, Joerg Schilling
Journal: Blood
Blood (2017) 130 (Supplement 1): 2180.
https://doi.org/10.1182/blood.V130.Suppl_1.2180.2180
Published: 2017
Journal Articles

Chemotherapy-Induced Nausea and Vomiting (CINV) - First Results of a German Non-Interventional Study with NEPA - a Netupitant/Palonosetron Fixed Dose Combination

Meinolf Karthaus, P Klare, V Heilmann, G Klausmann, Joerg Schilling
Journal: Blood
Blood (2016) 128 (22): 3614.
https://doi.org/10.1182/blood.V128.22.3614.3614
Published: 2016
Journal Articles

Cardiac Safety of NEPA, a Fixed-Dose Antiemetic Combination, Administered Prior to Anthracycline-Based Chemotherapy

Meinolf Karthaus, MD, Matti Aapro, MD, Giada Rizzi, M.Sc., Marco Palmas, MD
Journal: Blood
Blood (2014) 124 (21): 4821.
https://doi.org/10.1182/blood.V124.21.4821.4821
Published: 2014
Journal Articles

No Evidence Of Increased Cyclophosphamide Toxicity Associated With The Antiemetic Agent NEPA, a Fixed-Dose Combination Of Netupitant and Palonosetron

Lee Schwartzberg, MD, FACP, Cristina Oprean, MD, Servando Cardona-Huerta, MD, Giada Rizzi, M.Sc., Giorgia Rossi, MD, Marco Palmas, MD, Meinolf Karthaus, MD, Matti Aapro, MD
Journal: Blood
Blood (2013) 122 (21): 2949.
https://doi.org/10.1182/blood.V122.21.2949.2949
Published: 2013